Page last updated: 2024-11-04

succinylacetone and Graft vs Host Disease

succinylacetone has been researched along with Graft vs Host Disease in 4 studies

succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.

Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.

Research Excerpts

ExcerptRelevanceReference
" bioavailability was ca."1.29Suppression of graft-versus-host disease by succinyl acetone in a rat allogeneic bone marrow transplantation model. ( Bauer, R; Chang, TQ; Fidler, JM; Vitt, CR; Young, JD, 1993)
"Succinylacetone is a seven-carbon organic ketoacid that we have previously shown to inhibit tumor allograft rejection as well as the primary antibody response to sheep erythrocytes in rats."1.27Immunosuppression by succinylacetone. II. Prevention of graft-vs-host disease. ( Blaese, RM; Hess, RA; Tschudy, DP, 1987)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fidler, JM3
Chang, TQ1
Bauer, R1
Young, JD1
Vitt, CR1
Raff, RF2
Storb, R2
Graham, T2
Sale, GE1
Johnston, B1
Deeg, HJ2
Pepe, M2
Schuening, F2
Appelbaum, FR2
Sale, G1
Shulman, H1
Hess, RA1
Tschudy, DP1
Blaese, RM1

Other Studies

4 other studies available for succinylacetone and Graft vs Host Disease

ArticleYear
Suppression of graft-versus-host disease by succinyl acetone in a rat allogeneic bone marrow transplantation model.
    Transplantation, 1993, Volume: 55, Issue:2

    Topics: Animals; Bone Marrow Transplantation; Dose-Response Relationship, Drug; Female; Graft vs Host Diseas

1993
Pharmacologic, toxicologic, and marrow transplantation studies in dogs given succinyl acetone.
    Transplantation, 1992, Volume: 54, Issue:5

    Topics: Animals; Bone Marrow Transplantation; Dogs; Female; Graft Rejection; Graft vs Host Disease; Haploidy

1992
Succinyl acetone plus methotrexate as graft-versus-host disease prophylaxis in DLA-haploidentical canine littermate marrow grafts.
    Transplantation, 1992, Volume: 54, Issue:5

    Topics: Animals; Bone Marrow Transplantation; Dogs; Drug Therapy, Combination; Graft Survival; Graft vs Host

1992
Immunosuppression by succinylacetone. II. Prevention of graft-vs-host disease.
    Journal of immunology (Baltimore, Md. : 1950), 1987, Nov-01, Volume: 139, Issue:9

    Topics: Animals; Bone Marrow Transplantation; Cell Survival; Chimera; Graft vs Host Disease; Graft vs Host R

1987